ArticleCurrent medicinal chemistry2026

Metformin Reverses Progesterone Resistance in Endometrial Cancer by Targeting the AMPK-FOXO1-CALB2 Pathway.

Liangli Hong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.